✦ LIBER ✦

The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing–remitting multiple sclerosis

✍ Scribed by Giovanni Frisullo; Massimiliano Mirabella; Francesco Angelucci; Marcella Caggiula; Roberta Morosetti; Cristina Sancricca; Agata Katia Patanella; Viviana Nociti; Raffaele Iorio; Assunta Bianco; Valentina Tomassini; Carlo Pozzilli; Pietro Attilio Tonali; Giuseppe Matarese; Anna Paola Batocchi

Book ID: 113730152
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 1006 KB
Volume: 192
Category: Article
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2007.08.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leptin and its soluble receptor in plasm

Leptin and its soluble receptor in plasma of patients suffering from remitting–relapsing multiple sclerosis (MS): In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients

✍ Kokona Chatzantoni; Panagiotis Papathanassopoulos; Euthymia Gourzoulidou; Athana 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Effect of natalizumab on clinical and ra

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

✍ Melin, A.; Outteryck, O.; Collongues, N.; Zéphir, H.; Fleury, M. C.; Blanc, F.; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 305 KB

Effect of natalizumab on clinical and ra

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

Expression of chemokine receptor CXCR3 o

Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing–remitting multiple sclerosis

✍ Eckhart Sindern; Tanja Patzold; Ludgera Manuela Ossege; Astrid Gisevius; Jean-Pi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 133 KB

FP14-TU-03 The effect of disease duratio

FP14-TU-03 The effect of disease duration on grey matter volume and cognitive performance in relapsing-remitting multiple sclerosis patients

✍ A.A. Achiron; S. Tal; D. Magalashvili; A. Achiron 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Effect of laquinimod on MRI-monitored di

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ G Comi; A Pulizzi; M Rovaris; O Abramsky; T Arbizu; A Boiko; R Gold; E Havrdova; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 143 KB